Intravitreal Bevacizumab in Inflammatory Ocular Neovascularization

• Published in: American journal of ophthalmology Vol. 146; no. 3; pp. 410 - 416.e1
• Main Authors: Mansour, Ahmad M, Mackensen, Friederike, Arevalo, J. Fernando, Ziemssen, Focke, Mahendradas, Padmamalini, Mehio-Sibai, Abla, Hrisomalos, Nicholas, Lai, Timothy Y.Y, Dodwell, David, Chan, Wai-Man, Ness, Thomas, Banker, Alay S, Pai, Sivakami A, Berrocal, Maria H, Tohme, Rania, Heiligenhaus, Arnd, Bashshur, Ziad F, Khairallah, Moncef, Salem, Khalil M, Hrisomalos, Frank N, Wood, Matthew H, Heriot, Wilson, Adan, Alfredo, Kumar, Atul, Lim, Lyndell, Hall, Anthony, Becker, Matthias
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.09.2008; Elsevier; Elsevier Limited
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors - therapeutic use; Antibodies, Monoclonal - therapeutic use; Antibodies, Monoclonal, Humanized; Bevacizumab; Biological and medical sciences; Child; Choroidal Neovascularization - drug therapy; Choroidal Neovascularization - etiology; Choroidal Neovascularization - physiopathology; Diabetic retinopathy; Eye Diseases - complications; Female; Follow-Up Studies; Humans; Injections; Macular degeneration; Male; Medical imaging; Medical sciences; Middle Aged; Miscellaneous; Ophthalmology; Optic Disk - blood supply; Retinal Neovascularization - drug therapy; Retinal Neovascularization - etiology; Retinal Neovascularization - physiopathology; Retrospective Studies; Standard deviation; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A - antagonists & inhibitors; Visual Acuity - physiology; Vitreous Body; Antineoplastic agent; Immunomodulator; Eye; Vascular endothelium growth factor; Ocular; Vitreous body; Inflammation; Monoclonal antibody; Neovascularization; Ophthalmology; Antiangiogenic agent; Bevacizumab

Purpose To assess the role of bevacizumab in inflammatory ocular neovascularization. Design Retrospective, multicenter, consecutive case series of inflammatory ocular neovascularization. Methods Patients with inflammatory ocular neovascularization of varying causes for whom standard therapy failed w...